Dexmedetomidine attenuates inflammation and organ injury partially by upregulating Nur77 in sepsis
Open Access
- 21 June 2023
- journal article
- research article
- Published by Wiley in Immunity, Inflammation and Disease
- Vol. 11 (6) , e883
Abstract
Purpose: The aim of this study was to investigate the effect of dexmedetomidine (Dex) on inflammation and organ injury in sepsis, as well as the potential relationship between Dex and nuclear receptor 77 (Nur77).Methods: We investigated the effects of dexmedetomidine on lipopolysaccharide (LPS)‐induced inflammation in RAW264.7 cells and organ injury in the cecal ligation and puncture (CLP) mouse model. Additionally, we examined the relationship between dexmedetomidine and Nur77. The expression levels of Nur77 in RAW264.7 cells were analyzed under various types of stimulation using quantitative reverse transcription polymerase chain reaction and western blot analysis. Inflammatory cytokine levels in the cells were evaluated using enzyme‐linked immunoassay. Organ injuries were assessed by examining tissue histology and pathology of the lung, liver, and kidney.Results: Dexmedetomidine increased the expression of Nur77 and IL‐10, and downregulated inflammatory cytokines (IL‐1β and TNF‐α) in LPS‐treated RAW264.7 cells. The effect of dexmedetomidine on inhibiting inflammation in LPS‐treated RAW264.7 cells was promoted by overexpressing Nur77, while it was reversed by downregulating Nur77. Additionally, dexmedetomidine promoted the expression of Nur77 in the lung and CLP‐induced pathological changes in the lung, liver, and kidney. Activation of Nur77 with the agonist Cytosporone B (CsnB) significantly suppressed the production of IL‐1β and TNF‐α in LPS‐treated RAW264.7 cells. In contrast, knockdown of Nur77 augmented IL‐1β and TNF‐α production in LPS‐treated RAW264.7 cells.Conclusion: Dexmedetomidine can attenuate inflammation and organ injury, at least partially, via upregulating Nur77 in sepsis.Keywords
Funding Information
- National Natural Science Foundation of China (81701958, 81960357)
This publication has 47 references indexed in Scilit:
- The Effect of Dexmedetomidine Post-treatment on the Inflammatory Response of Astrocyte Induced by LipopolysaccharideCell Biochemistry and Biophysics, 2014
- Perioperative Dexmedetomidine Improves Mortality in Patients Undergoing Coronary Artery Bypass SurgeryJournal of Cardiothoracic and Vascular Anesthesia, 2014
- Resistance of LPS-activated bone marrow derived macrophages to apoptosis mediated by dexamethasoneScientific Reports, 2014
- Nur77 Decreases Atherosclerosis Progression in apoE−/− Mice Fed a High-Fat/High-Cholesterol DietPLOS ONE, 2014
- Bone marrow NR4A expression is not a dominant factor in the development of atherosclerosis or macrophage polarization in miceJournal of Lipid Research, 2013
- Dexmedetomidine and clonidine inhibit the function of NaV1.7 independent of α2-adrenoceptor in adrenal chromaffin cellsJournal of Anesthesia, 2011
- Immunodesign of experimental sepsis by cecal ligation and punctureNature Protocols, 2008
- Regulation of Macrophage Inflammatory Gene Expression by the Orphan Nuclear Receptor Nur77Molecular Endocrinology, 2006
- Anti‐Inflammatory and Antioxidative Effects of Propofol on Lipopolysaccharide‐Activated MacrophagesAnnals of the New York Academy of Sciences, 2005
- Clinical Uses of α2-Adrenergic AgonistsAnesthesiology, 2000